During the past decade, Methodist Healthcare conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Healthcare" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Glaxo Wellcome" with 2 trials sponsored, "Medical University of South Carolina" with 2 trials sponsored, "Stryker Neurovascular" with 2 trials sponsored and "AveXis, Inc." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Healthcare" #1 collaborator was "Vanderbilt University" with 2 trials as a collaborator, "Albany Medical College" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Indiana University" with 1 trials as a collaborator and "Methodist Health System" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Healthcare" are "HIV Infections" (4 trials), "Ischemic Stroke" (2 trials), "Aortic Insufficiency" (1 trials), "Aortic Regurgitation" (1 trials) and "Aortic Valve Disease" (1 trials). Many other conditions were trialed in "Methodist Healthcare" in a lesser frequency.

Most popular intervention types in "Methodist Healthcare" are "Drug" (10 trials), "Device" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Efavirenz" (2 trials), "GW433908" (2 trials), "Lamivudine" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Healthcare" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Methodist Healthcare". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Methodist Healthcare, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Healthcare, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".